Try our beta test site
27 studies found for:    Northwestern AND geriatrics or aging
Show Display Options
Rank Status Study
1 Completed
Has Results
Advance Planning for Home Services for Seniors
Condition: Alzheimers, Falls, Aging in Place
Interventions: Other: Plan Your Lifespan Website;   Other: Go4Life Website
2 Unknown  Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])
Conditions: Coronary Disease;   Cardiovascular Diseases
Intervention:
3 Recruiting SUSTAIN-IT: Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support?
Condition: Heart Failure
Intervention:
4 Completed
Has Results
The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination
Condition: Influenza Vaccination
Interventions: Behavioral: Fact Only Education Message;   Behavioral: Fact and Myth Educational Message;   Behavioral: Fact, Myth, Why Educational Message;   Behavioral: Control Educational Message
5 Recruiting Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders
Conditions: Impaired Cognition;   HIV Infection
Intervention: Behavioral: MBSR
6 Active, not recruiting Intervention to Enhance Lateral Balance Function and Prevent Falls in Aging
Condition: Accidental Falls
Intervention: Other: Physical Training Interventions
7 Active, not recruiting Online Peer Networked Collaborative Learning for Managing Depressive Symptoms
Condition: Depression
Intervention: Behavioral: iCBT for late life depression
8 Completed A Study of Immune System Activity in Healthy Adults
Conditions: HIV Infections;   HIV Seronegativity
Intervention:
9 Terminated
Has Results
Cetrorelix Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Condition: Benign Prostatic Hypertrophy
Interventions: Drug: Cetrorelix;   Drug: Placebo
10 Completed Doxycycline and OA Progression
Condition: Osteoarthritis
Intervention: Drug: Doxycycline
11 Completed Memory Impairment Study (Mild Cognitive Impairment Study)
Condition: Alzheimer Disease
Interventions: Drug: Donepezil;   Drug: Vitamin E
12 Completed Home-Based Assessment for Alzheimer Disease Prevention
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Interventions: Behavioral: Mail and Live Phone;   Behavioral: Interactive Voice Response (IVR);   Behavioral: Home-based Computer Kiosk;   Behavioral: Traditional Evaluation Instruments
13 Active, not recruiting The Testosterone Trial in Older Men
Condition: Andropause
Interventions: Drug: AndroGel® (testosterone gel);   Drug: Placebo
14 Active, not recruiting SILVER-AMI: Outcomes in Older Persons With Heart Attacks
Condition: Acute Myocardial Infarction
Intervention:
15 Recruiting Memory Improvement Through Nicotine Dosing (MIND) Study
Condition: Mild Cognitive Impairment
Interventions: Drug: Nicotine Transdermal Patch;   Drug: Placebo Patch
16 Completed
Has Results
DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: DHA (Docosahexaenoic Acid);   Drug: Placebo
17 Completed
Has Results
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 4.6 mg/24 h (5 cm^2);   Drug: Rivastigmine 9.5 mg/24 h (10 cm^2);   Drug: Rivastigmine 13.3 mg/24 h (15 cm^2);   Drug: Placebo
18 Completed Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Condition: Arthritis, Rheumatoid
Interventions: Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
19 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
20 Completed Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Safinimide 50-100 mg/day;   Drug: Matching Placebo

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.